Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 25398460.
- Also identified by DOI 10.1093/infdis/jiu633 and PMC identifier 4462656.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate whether distinct populations have differing human immunodeficiency virus type 1 (HIV) neutralizing antibody responses, we compared 20 women from Tanzania's HIV Superinfection Study (HISIS) cohort, who were infected multiple HIV subtypes, and 22 women from the Centre for the AIDS Programme of Research in South Africa (CAPRISA) cohort, who were infected exclusively with HIV subtype C. By 2 years after infection, 35% of HISIS subjects developed neutralization breadth, compared with 9% of CAPRISA subjects (P = .0131). Cumulative viral loads between 3 and 12 months were higher in the HISIS group (P = .046) and strongly associated with breadth (P < .0001). While viral load was the strongest predictor, other factors may play a role, as the odds of developing breadth remained higher in HISIS even after correction for viral load.
Medical subject headings
- Antibodies, Neutralizing
- HIV Antibodies
- HIV Infections
- HIV-1